- Your Challenges
- Offerings
- News & Events
- Knowledge Center
- About Us
- Diagnostics
CE Marked
For In Vitro Diagnostic Use
Accurate quantitation of the Epstein-Barr Virus (EBV) is critical to the monitoring of post-transplant lymphoproliferative disease (PTLD) in immunocompromised graft recipients. The Abbott RealTime EBV assay provides precise, reliable viral load results for supporting clinical management decisions.
The Abbott RealTime EBV assay has a low limit of quantification (corresponding to high sensitivity), which is helpful in transplant patients.
Leading Science
Enabling Solutions
Precision and Efficiency
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.